Dovitinib lactate hydrateProduct ingredient for Dovitinib
- Name
- Dovitinib lactate hydrate
- Drug Entry
- Dovitinib
Dovitinib is an orally active small molecule that exhibits potent inhibitory activity against multiple RTKs involved in tumor growth and angiogenesis. Preclinical data show that dovitinib works to inhibit multiple kinases associated with different cancers, including acute myeloid leukemia (AML) and multiple myeloma. Chiron currently has three ongoing Phase I clinical trials for dovitinib.
- Accession Number
- DBSALT002512
- Structure
Structure for Dovitinib lactate hydrate (DBSALT002512)
- Synonyms
- Dovitinib lactate